Multiple Sclerosis Therapy

In MS, less frequent treatment dosing schedule is equally effective

An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...

一些您可能无法访问的结果已被隐去。